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Results: 2854 patients treated with heparins were included. The risk of
major bleeding or transfusion (3.0% vs. 7.0%) and in-hospital death (3.2% vs
9.2%) was lower with LMWH compared with UFH, a difference that persisted
after multivariate adjustment (OR=0.51, 95% CI: 0.34-0.76 and OR=0.53,
95% CI: 0.37-0.76, respectively). Three-year survival and stroke and reinfarc-
tion-free survival were also higher with LMWH compared with UFH
(adjusted HR =0.73, 95% CI: 0.61-0.86 and HR =0.73, 95% CI: 0.62-0.85,
respectively). In two cohorts of patients matched on a propensity score for get-
ting LMWH and with similar baseline characteristics (834 patients per group),
major bleeding and transfusion were lower while three-year survival was sig-
nicantly higher in patients receiving LMWH.
Conclusion: The present data suggest that the use of LMWH in AMI
patients may have a better benefit/risk profile than UFH with in terms of
bleeding, need for transfusion, and long term survival.
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Background: Predictors of long-term outcome in optimally-treated
patients after AMI have not been extensively studied.
Aim: We assessed 3-year survival in a population of 3,262 patients from
the FAST-MI registry who were discharged alive after the acute episode.
Results: At hospital discharge, 1586 patients (49%) received optimal medical
treatment (OMT: antiplatelet + beta-blocker + statin + ACE-I or ARB agents).
Patients receiving OMT were younger (64±13 vs 69±14 years, p<0.001), had a
lower GRACE risk score (141 ±33 vs 151±36, p<0.001)and had more use of PCI
during index hospitalization (75% vs 56%,p<0.001). Three-year survival was 88%
in patients with OMT versus 77.5% in patients without (p<0.001). Cox multivar-
iate analysis was used to determine predictors of 3-year mortality and covariates
included age, sex, risk factors, comorbidities, type of AMI, CAD extent, use of
PCI, use of CABG, in-hospital complications, and other discharge medications.
Overall, adjusted HR for 3-year death was 0.82 (0.68-1.00), p=0.048, for patients
receiving OMT, confirming the benefit of comprehensive therapy beyond each of
its individual components. In the 1586 patients receiving OMT at discharge, inde-
pendent predictors of long-term death were age ≥75 years [HR 1.93 (1.03-3.64)];
AMI type and severity [STEMI vs NSTEMI: HR 0.64 (0.44-0.93); GRACE score:
HR 1.01 (1.00-1.01); LVEF< 40%: HR 2.03 (1.31-3.16); 3-vessel CAD: HR 2.12
(1.28-3.52)]; previous CV history [stroke: HR 1.91 (1.29-2.83), CHF: HR 1.79
(1.11-2.88)]; management with an invasive strategy [HR 0.31 (0.17-0.56)], and
associated conditions [history of diabetes HR 1.79 (1.28-2.49); history of cancer
HR 2.76 (1.75-4.33); current smoking at the time of AMI HR 1.88 (1.20-2.94)].
Conclusion: In patients receiving OMT after AMI, early invasive manage-
ment remains a significant predictor of improved survival, while associated
non cardiac conditions (and in particular cancer, diabetes, previous TIA or
stroke, and smoking) are major determinants of higher long-term mortality.
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Purpose: Death rate of acute coronary syndromes has decreased for more
than 50 years. Out-of-hospital mortality remains high despite improvements in
acute coronary syndrome’s care.
Aims: To evaluate the importance of out-of-hospital mortality and the
main determinants of in-hospital and one-year mortality in France.
Methods: Analyses were based on data from the French MONICA popu-
lation-based registry including exhaustively all acute coronary syndromes
occurring in people aged 35-74 during the year 2006 in 3 geographic areas.
First we evaluated out-of-hospital mortality. Then analyses were performed
through Cox models on incident ACS reaching the hospital alive in order to
determine main factors explaining the one-year mortality. Number of attribut-
able deaths was assessed for variables of interest.
Results: After a one-year follow-up, case-fatality was 29.3% for incident
events (n=2547) with 70.3% of out-of-hospital deaths and 21.1% occurring in
the 28 days following the event. The number of attributable deaths related to
3 situations with a strong impact identified from multivariate analyses (out-of-
hospital life-and-death emergency, hospitalization before ACS occurrence,
and lack of coronary angiography) was 130 (59% of deaths occurring after
reaching the hospital) during the one-year follow-up. These sub-groups were
corresponding to patients with an important initial state of severity and not
benefiting from traditionally recommended treatments.
Conclusion: The major part of deaths after ACS occurs in the out-of-hos-
pital phase. Moreover, the major part of one-year mortality is associated with
a very poor prognosis before medicalization. This underlines the importance
of cardiovascular prevention, population education and better out-of-hospital
emergency management.
012
Use of invasive strategy in non-ST-elevation myocardial infarction is
a major determinant of improved long-term survival. The FAST-MI
registry
Etienne Puymirat (1), Guillaume Taldir (2), Nadia Aissaoui (1), Gilles
Lemesle (3), Luc Lorgis (4), Thomas Cuisset (5), Pierre Bourlard (6),
Bruno Mailler (7), Gregory Ducrocq (8), Jean Ferrieres (9), Simon Tabas-
some (10), Nicolas Danchin (1)
(1) Hôpital Européen Georges Pomipdou (HEGP), cardiologie, Paris,
France – (2) Hôpital Européen Georges Pompidou, cardiologie, Paris,
France – (3) Regional and University Hospital of Lille, Lille, France –
(4) CHU Dijon, cardiologie, Dijon, France – (5) CHU Timones, Mar-
seille, France – (6) Groupe Hospitalier Mutualiste de Grenoble, Gre-
noble, France – (7) Hospital Center of Troyes, Troyes, France – (8) CHU
Bichat, Paris, France – (9) CHU Rangueil, Toulouse, France – (10) Hôpi-
tal Saint Antoine, cardiologie, Paris, France
Objectives: We assessed the impact of invasive strategy (IS) versus a
conservative strategy (CS) on in-hospital complications and three-year out-
comes in patients with Non-ST-Elevation Myocardial Infarction (NSTEMI)
from the FAST-MI registry.
Background: Results from randomized trials comparing IS and CS in
patients with NSTEMI are conflicting.
Methods: Of the 3,670 patients in the FAST-MI registry, which included
patients with acute myocardial infarction (within 48 hours) over a one-month
period in France at the end of 2005, 1,645 presented with NSTEMI.
Results: Of the 1,645 patients analyzed, 80% had an IS. Patients in the IS
group were younger (67±12 vs. 80±11 years), less often women (29% vs.
51%) and had a lower GRACE risk score (137±36 vs. 178±34) as compared
with patient treated with CS. In-hospital mortality and blood transfusions were
significantly more frequent in patients with CS as compared with IS (13.1 vs.
2.0%, 9.1 vs. 4.6%). Use of IS was associated with a significant reduction in
3-year mortality and cardiovascular death (17% vs. 60%, adjusted HR: 0.44;
95%CI: 0.35-0.55 and 8% vs. 36%, adjusted HR: 0.37; 95%CI: 0.27-0.50).
